Reury-Perng Perng

Mutation in the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor Is a Predictive and Prognostic Factor for Gefitinib Treatment in Patients with Non–Small Cell Lung Cancer

Teh‐Ying Chou, Chao‐Hua Chiu, Ling‐Hui Li et al. · Clinical Cancer Research · 2005 · 322 citations

Medicine, Oncology, Pharmacology +16

Vandetanib Versus Placebo in Patients With Advanced Non–Small-Cell Lung Cancer After Prior Therapy With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor: A Randomized, Double-Blind Phase III Trial (ZEPHYR)

Jin Soo Lee, Vera Hirsh, Keunchil Park et al. · Journal of Clinical Oncology · 2012 · 231 citations

Medicine, Oncology, Pharmacology +10

Foreign Body Aspiration Into the Lower Airway in Chinese Adults

Chung-Hua Chen, Chun‐Liang Lai, Tsung-Tsung Tsai et al. · CHEST Journal · 1997 · 221 citations

Medicine, Clinical Sciences, Otolaryngology +15

Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study

Alex Y. Chang, Purvish M. Parikh, Sumitra Thongprasert et al. · Journal of Thoracic Oncology · 2006 · 168 citations · Full text

Medicine, Oncology, Pharmacology +7

Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity

Chao‐Hua Chiu, Chun‐Ming Tsai, Yuh‐Min Chen et al. · Lung Cancer · 2004 · 143 citations

Medicine, Oncology, Pharmacology +13